Prism Medico & Pharmacy Ltd Financials
Company Logo

Prism Medico & Pharmacy Ltd Financial Statement

Prism Medico & Pharmacy Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue0.06
Operating Expense0.15
Net Profit-0.09
Net Profit Margin-150.00
Earning Per ShareTBA
EBIDTA-0.09
Effective Tax RateTBA
Invest in Prism Medico & Pharmacy Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Prism Medico & Pharmacy Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual2.93
Operating Expenses Annual3.06
Operating Profit Annual-0.02
Interest Annual0.01
Depreciation0.01
Net Profit Annual-0.02
Tax Annual-0.01

Prism Medico & Pharmacy Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.10
Cash Flow from Operations-0.01
Cash Flow from InvestingTBA
Cash Flow from Financing-0.01
Cash Flow at the End0.08

Prism Medico & Pharmacy Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)-0.34
PBIT Margin (%)-0.68
PBT Margin (%)67.58
Net PROFIT Margin (%)-0.68
Return On Networth / Equity (%)-0.13
Return On Networth /Employed (%)-0.13
Return On Assets (%)-0.13
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)0.19

Prism Medico & Pharmacy Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.03
Total Current Assets Annual14.99
Non Current Assets Annual0.25
Total Shareholders Funds Annual15.14
Total Assets Annual15.24

Prism Medico & Pharmacy Ltd Earning Calls

EPS (INR)

Expected

0.00

Reported

-0.07

Surprise

0.00%

Sep 2019

EPS beaten by 0.00%

Jun 2019

EPS beaten by 0.00%

Mar 2019

EPS beaten by 0.00%

Get Your FAQs Right

As of Nov 8, 2024, Prism Medico & Pharmacy Ltd has a market capitalization of 16.54 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Prism Medico & Pharmacy Ltd is debt-free with a debt-to-equity ratio of 0.00.
In FY 2023 , Prism Medico & Pharmacy Ltd recorded a total revenue of approximately 2.93 Cr marking a significant milestone in the company's financial performance.
Prism Medico & Pharmacy Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.6% and -0.5% annually, respectively..
Prism Medico & Pharmacy Ltd's current PE ratio is -827.00.
Prism Medico & Pharmacy Ltd's ROCE averaged -1.6% from the FY ending March 2022 to 2024, with a median of -0.7%. It peaked at -0.1% in March 2024, reflecting strong capital efficiency over the period..
Prism Medico & Pharmacy Ltd's latest EBIT is Rs. -0.02 Cr, surpassing the average EBIT of Rs. -0.21 Cr over the 5 years..